Are peptides legal in the UK?
It depends on the peptide, and on whether you’re selling it or using it yourself. Here is what UK law says, with the sources.
Last updated 30 October 2026
The short answer
- Licensed peptide medicines (Wegovy, Ozempic, Mounjaro, Saxenda) are legal, but prescription only.
- Unlicensed peptides (BPC-157, TB-500, retatrutide and others) can’t legally be sold as treatments, whatever the label says.
- For your own use, medicines law targets selling and supplying rather than buying, with exceptions for a few peptide hormones that are controlled drugs.
Three kinds of peptide
| Kind | Examples | UK status |
|---|---|---|
| Licensed medicines | Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro), liraglutide (Saxenda) | Legal. Prescription only: they can only be supplied against a prescription. |
| Unlicensed peptides | BPC-157, TB-500, CJC-1295/ipamorelin, MOTS-c, retatrutide (in trials), melanotan II | No UK licence. Selling one as a treatment, or offering to, is a criminal offence. |
| Cosmetic and food peptides | GHK-Cu serums, collagen peptides | Legal under cosmetics or food law, as long as they make no medicinal claims. Injectables are not cosmetics. |
When a peptide counts as a medicine
Under the Human Medicines Regulations 2012 (regulation 2), a product is a medicine if it is presented as treating or preventing disease, or if it is used to restore, correct or modify how the body works. So the same powder can be a medicine or not, depending on how it’s sold and what it does.
The MHRA decides case by case, looking at labels, packaging, websites and claims. A “research use only” or “not for human consumption” label isn’t a defence: its guidance (Guidance Note 8) says a statement that a product is not medicinal “is not in itself conclusive”, and an MHRA official was quoted in the trade press (Pharmacy Business, April 2026) saying it disregards “research purposes” claims used to get round the rules.
Selling and supplying
- Unlicensed medicines: it is an offence to sell or supply, or offer to sell or supply, a medicine with no UK authorisation (regulations 46 and 47). The maximum penalty is two years in prison, an unlimited fine, or both.
- Prescription only medicines: they may only be supplied against a prescription from an appropriate practitioner, such as a doctor, a dentist, or a nurse or pharmacist independent prescriber (regulation 214). Breaking this, or possessing one intending to supply it without a prescription, is an offence (regulation 255).
- Injecting someone else with a prescription only medicine is restricted to prescribers and people acting on their directions. Injecting yourself is not.
- Giving it away counts: passing a medicine to someone else, even for free, is “supply”.
The only routine lawful route to an unlicensed medicine is a “special” ordered by a prescriber for their own patient (regulation 167). It isn’t a shop route.
Buying for your own use
The offences in medicines law are about selling, supplying, giving to others and possessing with intent to supply. We found no provision that makes it an offence to buy or possess a medicine purely for your own use, and importing a medicine “for administration to himself or herself” is exempt from the import licence rules (regulation 17(6)). That’s our reading of the regulations, not an MHRA statement, so treat it as a general explanation rather than legal advice.
In practice:
- Border rules apply: if you bring in more than three months’ supply, or have medicine posted to you, it can be taken away (GOV.UK).
- Some peptide hormones are controlled drugs. Growth hormone (somatropin) and HCG are Class C. In Great Britain, possessing them for your own use isn’t an offence, but supplying them is, and the import exemption covers only bringing them in in person, not by post. BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, retatrutide, melanotan and IGF-1 are not controlled drugs.
- The real risk is the product. The MHRA has seized tens of thousands of fake and unlicensed doses (see below). With no licence, nobody has checked what is in the vial.
Advertising
Prescription only medicines can’t be advertised to the public (regulation 284; CAP Code rule 12.12), and neither can unlicensed medicines (regulation 279). The ASA treats phrases like “weight loss injections”, “skinny jab” and “GLP-1”, pen images, per pen prices and “once a week” claims as advertising a prescription only medicine. Providers can advertise a weight loss consultation, as long as they don’t imply a particular medicine will follow.
What the regulator is doing
- 29 May 2026: about 12,000 doses seized near Northampton, the MHRA’s largest ever seizure of unlicensed weight loss medicines, with two arrests. The site made retatrutide and tirzepatide “as well as peptide products”.
- 24 July 2026: the MHRA confirmed retatrutide “has not been authorised for use in the UK”, and told the public to walk away if a weight loss medicine is offered without a prescription.
- 14 October 2026: more than 12,000 counterfeit retatrutide and tirzepatide pens seized in Birmingham, worth about £2 million (announced 15 October).
- Peptide clinics: in April 2026 the MHRA was reported to be investigating clinics offering peptide injections with medicinal claims. We have found no published outcome as of this guide’s date.
- Melanotan: the MHRA classes melanotan II injections and pens as medicines and has advised anyone using it to stop and report side effects.
Sport
Many peptides are banned for athletes. On the WADA 2026 Prohibited List, BPC-157 is banned under S0 (non approved substances); TB-500, CJC-1295, ipamorelin, growth hormone and IGF-1 under S2; MOTS-c and insulins under S4. The 2027 list, in force from 1 January 2027, makes clear that peptides still in clinical development can be prohibited even if they aren’t named. GLP-1 medicines are not on the list. If you’re tested, ask UKAD before you take anything.
Getting a licensed peptide medicine legally
- On the NHS, if you meet the criteria. See which NHS route applies to you.
- Privately, with a prescription from a qualified prescriber, supplied by a registered pharmacy.
Before you start, check who you’re dealing with:
- Pharmacies, including online ones: the GPhC register in Great Britain, or the PSNI register in Northern Ireland.
- Clinics and online doctor services: the CQC in England, Healthcare Improvement Scotland, Healthcare Inspectorate Wales, or the RQIA in Northern Ireland. (Online-only services based in Scotland may not be registered with Healthcare Improvement Scotland.)
- Doctors: the GMC register.
Every provider in our directory is already matched to one of these registers, with a link to check it yourself. How we verify providers.
Common questions
- Are peptides legal in the UK?
- Some are, some are not. Licensed peptide medicines such as Mounjaro, Wegovy and Saxenda are legal but prescription only. Peptides with no UK licence, such as BPC-157 and TB-500, cannot legally be sold as treatments. Peptides in skincare, such as GHK-Cu serums, are legal as cosmetics if they make no medicinal claims.
- Is it illegal to buy peptides online for my own use?
- UK medicines law mainly targets people who sell or supply medicines, not people who buy them for themselves, and importing a medicine for your own use is exempt from the import licence rules. Some peptide hormones, such as growth hormone and HCG, are Class C controlled drugs: in Great Britain you can possess them for your own use, but supplying them, or importing them other than in person, is not covered. Unlicensed products may also be fake or contaminated. This is a general explanation, not legal advice.
- Does a “research use only” label make a peptide legal to sell?
- No. The MHRA decides case by case whether a product is a medicine, looking at how it is presented and what it does. An MHRA official has been quoted in the trade press saying it disregards “research purposes” claims used to avoid medicines rules. A product sold for injection, or with health claims, can still be treated as an unlicensed medicine.
- Can I get BPC-157, TB-500 or retatrutide on prescription?
- Not as a licensed medicine: none of them has a UK marketing authorisation. The MHRA says retatrutide “has not been authorised for use in the UK”, and that outside authorised clinical trials it is “likely illegal”.
- How do I get a licensed weight loss medicine legally?
- Through the NHS if you meet the criteria, or privately with a prescription from a qualified prescriber, supplied by a registered pharmacy. In Great Britain, check the pharmacy on the GPhC register; in Northern Ireland, on the PSNI register. For an online doctor service in England, check that it is registered with the CQC.
- Can a clinic or pharmacy advertise weight loss injections?
- No. Prescription only medicines cannot be advertised to the public. The ASA treats terms like “weight loss injections”, pen images and per pen prices as advertising a prescription only medicine. A provider may advertise a weight loss consultation, as long as it doesn’t imply you will get a particular medicine.
- Are peptides banned in sport?
- Many are. On the WADA 2026 list, BPC-157 is prohibited under S0 (non approved substances); TB-500, CJC-1295, ipamorelin, growth hormone and IGF-1 under S2; and MOTS-c under S4. The 2027 list, in force from 1 January 2027, makes clear that peptides still in clinical development can be prohibited even if they are not named. GLP-1 medicines are not on the list.
- What should I do if I’ve had a reaction, or think a product is fake?
- Stop using it, speak to a doctor, pharmacist or nurse, and report it to the MHRA through the Yellow Card scheme, which also takes reports of suspected fake medicines.
Sources
- Human Medicines Regulations 2012 (legislation.gov.uk): regs 2, 17, 46, 47, 214, 255, 279, 284
- Human Medicines Regulations 2012, reg 167 (specials) and reg 303 (advertising offences)
- MHRA Guidance Note 8: a guide to what is a medicinal product (2025 edition)
- Pharmacy Business: MHRA investigating peptide injection claims (7 Apr 2026, trade press)
- MHRA FOI 24/274: melanotan II (17 Apr 2024)
- WADA 2026 Prohibited List
- Misuse of Drugs Act 1971, Schedule 2 Part III (Class C)
- Misuse of Drugs Regulations 2001, reg 4
- MHRA: Borderline products, how to tell if your product is a medicine (updated 2 Jul 2026)
- MHRA: No summer shortcut for safe weight loss (24 Jul 2026)
- MHRA: largest ever seizure of unlicensed weight loss medicines (29 May 2026)
- MHRA: counterfeit weight loss pens worth £2 million seized (15 Oct 2026)
- ASA: weight control and prescription only medicines (29 May 2026)
- UKAD: 2027 Prohibited List summary of changes (14 Oct 2026)
- CQC: choosing an online healthcare service (updated 14 Apr 2026)
- GOV.UK: take medicine in or out of the UK
This guide explains the law in general terms as of 30 October 2026. It isn’t legal or medical advice.